DekaBank Deutsche Girozentrale - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 293 filers reported holding HAEMONETICS CORP in Q2 2018. The put-call ratio across all filers is 13.32 and the average weighting 0.1%.

Quarter-by-quarter ownership
DekaBank Deutsche Girozentrale ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$239
+191.5%
2,657
+172.8%
0.00%
Q2 2023$82
-100.0%
974
-51.1%
0.00%
-100.0%
Q1 2021$220,000
-5.6%
1,9920.0%0.00%0.0%
Q4 2020$233,000
-84.6%
1,992
-85.5%
0.00%
-88.9%
Q1 2019$1,513,0000.0%13,7490.0%0.01%0.0%
Q3 2018$1,513,000
+45.8%
13,749
+18.7%
0.01%
+28.6%
Q2 2018$1,038,00011,5840.01%
Other shareholders
HAEMONETICS CORP shareholders Q2 2018
NameSharesValueWeighting ↓
Nitorum Capital, L.P. 413,122$16,608,0004.78%
Altalis Capital Management LLC 88,055$3,540,0003.97%
RUTABAGA CAPITAL MANAGEMENT LLC/MA 513,619$20,647,0003.54%
Black Creek Investment Management Inc. 1,118,613$44,968,0003.46%
HealthCor Management, L.P. 1,150,000$46,230,0002.61%
Van Berkom & Associates Inc. 1,136,971$45,706,0001.83%
AMERICAN CAPITAL MANAGEMENT INC 567,896$22,829,0001.77%
FULLER & THALER ASSET MANAGEMENT, INC. 2,062,539$82,914,0001.25%
Legato Capital Management LLC 1,336$53,707,0000.97%
HEARTLAND ADVISORS INC 351,314$14,123,0000.78%
View complete list of HAEMONETICS CORP shareholders